Previous close | 202.77 |
Open | 202.39 |
Bid | 203.87 x 1800 |
Ask | 204.98 x 800 |
Day's range | 201.49 - 204.95 |
52-week range | 161.65 - 262.00 |
Volume | |
Avg. volume | 532,525 |
Market cap | 10.488B |
Beta (5Y monthly) | 1.37 |
PE ratio (TTM) | 22.18 |
EPS (TTM) | 9.22 |
Earnings date | 20 Feb 2024 - 26 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 211.04 |
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Charles River's (CRL) share price is likely to grow, backed by the strength of the DSA segment.
Charles River (CRL) and GC4K announce a gene therapy manufacturing collaboration.